AstraZeneca shares fall 5% on disappointing lung cancer drug trial
AstraZeneca Shares fell more than 5% on Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical…
health care industry
Eli Lilly could become the first $1 trillion healthcare stock
A sign with the company logo is displayed outside the headquarters of Eli Lilly and Company in Indianapolis, Indiana, on…
Abbott launches its first over-the-counter continuous glucose monitor in the US
A man wearing Abbott's Lingo biosensor. Courtesy of Abbott Abbott Laboratories announced Thursday that its over-the-counter continuous glucose monitor, Lingo,…
GE Healthcare shows signs of life, but lingering uncertainty keeps us on the sidelines
Each weekday, the CNBC Investing Club with Jim Cramer publishes the home stretch, a handy evening update, just in time…
We're making nearly 300% gains on a rising pharmaceutical stock
Shortly after the opening bell, we will sell 10 shares of Eli Lilly at approximately $958 each. Following Monday's trade,…
Inside the legendary Epic Systems campus, a world away from Wall Street
A sign that says “Epic Intergalactic Headquarters” on campus. Epic Systems Dorothy Gale was right: the Land of Oz is…
FDA authorizes Novavax's Covid-19 vaccine targeting JN.1
This illustration taken on January 16, 2022, shows a vial labeled “Novavax V COVID-19 Vaccine.” Dado Ruvic | Reuters The…
New Covid vaccines from Pfizer and Moderna: what you need to know
Moderna Covid-19 Vaccine mRNA Formula 2024-2025. Courtesy: Moderna A version of this article first appeared in CNBC's Healthy Returns newsletter,…
Eli Lilly launches new, cheaper form of weight-loss drug
An injection pen for Eli Lilly's weight-loss drug Zepbound is displayed in New York City on December 11, 2023. Brendan…
Dexcom launches Stelo, its first over-the-counter continuous glucose monitor
Zoom iconArrows pointing outwards User using Dexcom Stelo CGM. Courtesy of Dexcom Dexcom On Monday, Stelo, the new over-the-counter continuous…